WDGJF yields 512.82% · PFE yields 6.13%● Live data
📍 WDGJF pulled ahead of the other in Year 1
Combined, WDGJF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WDGJF + PFE for your $10,000?
John Wood Group PLC, together with its subsidiaries, provides consulting, project management, and engineering solutions to energy and built environment worldwide. It operates through four segments: Projects, Operations, Consulting, and Investment. The company offers engineering solutions, including decarbonization and optimization in energy and industry; and renewable energy, future fuels, and low carbon solutions. It also provides environment and infrastructure solutions comprising environmental studies and compliance, environmental remediation, public infrastructure, and geotechnical and materials services; clean energy solutions; mine planning and design, mineral processing and metallurgy, mineral resources and project assessment services; and automation and control solutions, such as asset protection and facility and process automation solutions, as well as simulation, learning, and virtual systems. In addition, the company offers subsea and export systems, including subsea, umbilical, riser, and flowline design, as well as planning, design, and development of marine terminals and pipelines; and hull and marine services. It serves oil and gas, infrastructure, industrial and manufacturing, mining, power, and government sectors. John Wood Group PLC was incorporated in 1961 and is headquartered in Aberdeen, the United Kingdom.
Full WDGJF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.